Researchers at the Stanford University School of Medicine say that a potential cancer vaccine that shows to eliminate all traces of tumors in mice is more than promising.
AJC reports that as a result, human trials are set to commence.
Researchers injected small amounts of two immune-stimulating agents directly into the the mice’s tumors, which were described as “solid.” As a result, the cancerous cells were completely obliterated.
“When we use these two agents together, we see the elimination of tumors all over the body,” Dr. Ronald Levy, professor of oncology, said. “This approach bypasses the need to identify tumor-specific immune targets and doesn’t require wholesale activation of the immune system or customization of a patient’s immune cells.”
The researchers conducted the experiment of roughly 90 mice. They published their findings in Science Translational Medicine, and said they had “developed a practical strategy for immunotherapy of cancer.”
Read more here.